Cary Street Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Buy
38,836
+917
+2% +$74K 0.07% 268
2026
Q1
$2.68M Buy
37,919
+1,575
+4% +$118K 0.07% 277
2025
Q4
$2.87M Buy
36,344
+2,183
+6% +$173K 0.07% 265
2025
Q3
$2.81M Buy
34,161
+3,305
+11% +$260K 0.07% 271
2025
Q2
$2.48M Buy
30,856
+6,548
+27% +$505K 0.07% 282
2025
Q1
$1.95M Buy
24,308
+1,665
+7% +$138K 0.06% 291
2024
Q4
$1.85M Buy
+22,643
New +$1.88M 0.06% 281

Other funds holding MET

Cary Street Partners's MET Position: Q2 2026 in Review

Cary Street Partners increased its MetLife (MET) stake by 2.4% in Q2 2026, buying an estimated $74K and bringing the position to 38,836 shares worth $3.29M. The position accounts for 0.07% of the portfolio, ranked #268.

Cary Street Partners first reported a position in MET in Q4 2024 and has held it in 7 quarters since. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Cary Street Partners held 38,836 shares of MetLife worth $3.29M as of Q2 2026.
  • Cary Street Partners bought 917 MetLife shares in Q2 2026, an estimated $74K.
  • MetLife made up 0.07% of Cary Street Partners's portfolio in Q2 2026, its #268 holding.
  • Cary Street Partners first reported a position in MetLife in Q4 2024 and has held it in 7 quarters since.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.